PT2933251T - Composição farmacêutica que pode ser utilizada para o tratamento de uma patologia do pé de um mamífero ungulado - Google Patents

Composição farmacêutica que pode ser utilizada para o tratamento de uma patologia do pé de um mamífero ungulado

Info

Publication number
PT2933251T
PT2933251T PT151634540T PT15163454T PT2933251T PT 2933251 T PT2933251 T PT 2933251T PT 151634540 T PT151634540 T PT 151634540T PT 15163454 T PT15163454 T PT 15163454T PT 2933251 T PT2933251 T PT 2933251T
Authority
PT
Portugal
Prior art keywords
ungulated
pathology
mammalian
foot
treatment
Prior art date
Application number
PT151634540T
Other languages
English (en)
Original Assignee
Peter Weyts
Celine Bourgeois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peter Weyts, Celine Bourgeois filed Critical Peter Weyts
Publication of PT2933251T publication Critical patent/PT2933251T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/322,3-Dihydro derivatives, e.g. flavanones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT151634540T 2014-04-15 2015-04-14 Composição farmacêutica que pode ser utilizada para o tratamento de uma patologia do pé de um mamífero ungulado PT2933251T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1453382A FR3019820B1 (fr) 2014-04-15 2014-04-15 Composes de type flavonoides pour leur utilisation dans le traitement d'une pathologie du pied d'un mammifere ongule-composition pharmaceutique associee

Publications (1)

Publication Number Publication Date
PT2933251T true PT2933251T (pt) 2021-08-13

Family

ID=51483548

Family Applications (1)

Application Number Title Priority Date Filing Date
PT151634540T PT2933251T (pt) 2014-04-15 2015-04-14 Composição farmacêutica que pode ser utilizada para o tratamento de uma patologia do pé de um mamífero ungulado

Country Status (5)

Country Link
EP (1) EP2933251B1 (pt)
ES (1) ES2881547T3 (pt)
FR (1) FR3019820B1 (pt)
MA (1) MA38619A (pt)
PT (1) PT2933251T (pt)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2710844B1 (fr) * 1993-10-07 1995-12-29 Bidel Christian Georges Composition pour le traitement ou la prévention de l'herpès.
US6528042B1 (en) * 1999-10-08 2003-03-04 Galileo Laboratories, Inc. Compositions of flavonoids for use as cytoprotectants and methods of making and using them
US20030125264A1 (en) * 2001-12-29 2003-07-03 Kimberly-Clark Worldwide, Inc. Methods For Treating Wounds
AU2004298356A1 (en) * 2003-12-18 2005-06-30 Nestec S.A. Composition for improving skin, hair and coat health containing flavanones
GB0505756D0 (en) * 2005-03-21 2005-04-27 Mars Uk Ltd Method
US20080317885A1 (en) * 2005-07-15 2008-12-25 Baker Donald J Compositions and Methods for Treating and Preventing Inflammatory and/or Degenerative Processes in Humans and Other Animals
ITMI20052461A1 (it) * 2005-12-22 2007-06-23 Univ Degli Studi Milano Sistemi microparticellari per la somministrazione orale di sostanze biologicamente attive
DE502007002101D1 (de) * 2007-03-12 2010-01-07 Dobavet Gmbh Arzneimittel mit Dobesilat-Calcium zur Behandlung und Prophylaxe von Sehnenerkrankungen
MX2007011002A (es) * 2007-09-07 2009-03-09 World Trade Imp Export Wtie Ag Composicion farmaceutica que comprende la combinacion de diversos agentes venotonicos y vasoprotectores para el tratamiento de la insuficiencia venosa cronica.
US8557275B2 (en) * 2009-07-23 2013-10-15 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
EP2353596A1 (en) * 2010-02-02 2011-08-10 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency
FI20106119A0 (fi) * 2010-10-27 2010-10-27 Sirtuin Valley Oy Energia-aineenvaihduntaan vaikuttava koostumus

Also Published As

Publication number Publication date
MA38619A (fr) 2021-06-02
EP2933251A1 (fr) 2015-10-21
FR3019820A1 (fr) 2015-10-16
EP2933251B1 (fr) 2021-07-07
ES2881547T3 (es) 2021-11-29
FR3019820B1 (fr) 2017-07-21

Similar Documents

Publication Publication Date Title
EP3493799A4 (en) CANNABIS
EP3476386C0 (en) LIQUID PHARMACEUTICAL COMPOSITION
DK3256138T3 (da) Farmaceutiske sammensætninger omfattende meloxicam
EP3513809A4 (en) MEDICAL COMPOSITION
EP3493798A4 (en) CANNABIS
DK3532029T3 (da) Flydende farmaceutisk sammensætning
DK3102213T3 (da) Farmaceutiske sammensætninger til behandlingen af inflammatoriske lidelser
MA54716A (fr) Réduction de la viscosité de formulations pharmaceutiques
DK3237045T3 (da) Indretning til indgivelse af lægemidler
LT3116491T (lt) Terapiškai aktyvių junginių farmacinės kompozicijos
BR112016021034A2 (pt) Composição farmacêutica, uso de tal composição, método para tratar uma doença e kit
DK3554534T3 (da) Farmaceutisk sammensætning omfattende insulin
BR112016020181A2 (pt) Composições de ácido lipoico éster colina e métodos de uso.
BR112016020260A2 (pt) uso de um composto na fabricação de um medicamento para tratar uma doença colestática intra-hepática
PL3207149T3 (pl) Kompozycja farmaceutyczna o zwiększonej stabilności
EP3402470A4 (en) STABLE PHARMACEUTICAL COMPOSITION
PT3360547T (pt) Composição farmacêutica bactericida que compreende ibuprofeno
PT3094616T (pt) O uso de uma composição que contém tribenzoato de glicerilo em distúrbios neurodegenerativos
EP3383371A4 (en) PHARMACEUTICAL FORMULATION
BR112017007753A2 (pt) uso de uma composição cosmética que compreende ácido 10-hidroxiesteárico.
BR112016030507A2 (pt) Compostos relacionados à vitamina d, composição farmacêutica, e kit
DK3313370T3 (da) Oftalmologisk farmaceutisk sammensætning
DK3096775T5 (da) SOCS-mimetika til behandling af sygdomme
EP3524250A4 (en) PHARMACEUTICAL COMPOSITION
PL3203998T3 (pl) Podstawione związki aromatyczne i kompozycje farmaceutyczne do zapobiegania i leczenia cukrzycy